OHA, oral hypoglycemic agent
Submit the internal appeal within 180 days
GLP-1 and GLP-1 receptor agonists mechanism of action triggers a series of responses that can aid in both glucose regulation and weight loss: Insulin release: GLP-1 stimulates the pancreas to release insulin
If you purchased the medication from an unreputable social media ad or an unlicensed website without a doctors consultation, do not use it
Seek medical advice if you experience severe or persistent nausea and vomiting that prevents adequate fluid intake, signs of pancreatitis (severe abdominal pain radiating to the back), symptoms of thyroid tumors (neck mass, difficulty swallowing, persistent hoarseness), or signs of acute kidney injury (decreased urination, swelling)
While the rate of weight loss depends on your baseline metabolic rate, many patients report a noticeable decrease in appetite and initial weight reduction within the first two to four weeks of beginning therapy